Applications of Next-generation Sequencing in Systemic Autoimmune Diseases

Systemic autoimmune diseases are a group of heterogeneous disorders caused by both genetic and environmental factors. Although numerous causal genes have been identified by genome-wide association studies (GWAS), these susceptibility genes are correlated to a relatively low disease risk, indicating that environmental factors also play an important role in the pathogenesis of disease. The intestinal microbiome, as the main symbiotic ecosystem between the host and host-associated microorganisms, has been demonstrated to regulate the development of the body’s immune system and is likely related to genetic mutations in systemic autoimmune diseases. Next-generation sequencing (NGS) technology, with high-throughput capacity and accuracy, provides a powerful tool to discover genomic mutations, abnormal transcription and intestinal microbiome identification for autoimmune diseases. In this review, we briefly outlined the applications of NGS in systemic autoimmune diseases. This review may provide a reference for future studies in the pathogenesis of systemic autoimmune diseases.

[1]  M. Z. Cader,et al.  Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene , 2012, Neurology.

[2]  J. Casanova,et al.  An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. , 2013, Immunity.

[3]  A. Koch.  The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.

[4]  M. Brown,et al.  Microbes, the gut and ankylosing spondylitis , 2013, Arthritis Research & Therapy.

[5]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[6]  Ken Chen,et al.  Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.

[7]  B. Namjou,et al.  The genetics of systemic lupus erythematosus and implications for targeted therapy , 2011, Annals of the rheumatic diseases.

[8]  F. Baas,et al.  Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity , 2013, Annals of the rheumatic diseases.

[9]  Identification of candidate risk gene variations by whole-genome sequence analysis of four rat strains commonly used in inflammation research , 2014, BMC Genomics.

[10]  Benjamin Meder,et al.  Next-generation sequencing entering the clinical arena. , 2011, Molecular and cellular probes.

[11]  F. Turroni,et al.  Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus , 2014, mBio.

[12]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[13]  L. Proctor,et al.  The Human Microbiome Project in 2011 and beyond. , 2011, Cell host & microbe.

[14]  Frode Vartdal,et al.  High‐throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV‐reactive CD8+ T cells , 2014, European journal of immunology.

[15]  G. Pesole,et al.  Epstein-Barr virus genetic variants are associated with multiple sclerosis , 2015, Neurology.

[16]  A. Venkatesan,et al.  Gut Microbiota in Multiple Sclerosis , 2015, Journal of Investigative Medicine.

[17]  F. Baas,et al.  Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease. , 2012, Annals of the rheumatic diseases.

[18]  Joshua C. Denny,et al.  Integration of Sequence Data from a Consanguineous Family with Genetic Data from an Outbred Population Identifies PLB1 as a Candidate Rheumatoid Arthritis Risk Gene , 2014, PloS one.

[19]  J. Bach,et al.  The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update , 2010, Clinical and experimental immunology.

[20]  T. Dörner,et al.  Immunopathogenic mechanisms of systemic autoimmune disease , 2013, The Lancet.

[21]  Stephan Ripke,et al.  Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis. , 2013, American journal of human genetics.

[22]  S. Robson,et al.  An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signaling , 2014, Nature Communications.

[23]  K. Münger,et al.  99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Epstein–Barr virus and multiple sclerosis: epidemiological evidence , 2010, Clinical and experimental immunology.

[24]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[25]  C. Huttenhower,et al.  Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis , 2013, eLife.

[26]  G. Illei,et al.  MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. , 2011, Arthritis and rheumatism.

[27]  Mhairi Marshall,et al.  Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis , 2014, Arthritis & rheumatology.

[28]  P. O’Toole,et al.  Next-generation sequencing technologies and their impact on microbial genomics. , 2013, Briefings in functional genomics.

[29]  A. Zhernakova,et al.  Detecting shared pathogenesis from the shared genetics of immune-related diseases , 2009, Nature Reviews Genetics.

[30]  B. Johnson,et al.  Impact of dietary deviation on disease progression and gut microbiome composition in lupus‐prone SNF1 mice , 2015, Clinical and experimental immunology.

[31]  V. Fischetti,et al.  Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease , 2013, PloS one.

[32]  L. Rönnblom,et al.  RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE , 2013, PloS one.

[33]  Simon A. Jones,et al.  Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production , 2014, Nature Medicine.

[34]  M. Friedländer,et al.  Computational Prediction of miRNA Genes from Small RNA Sequencing Data , 2015, Front. Bioeng. Biotechnol..

[35]  Xiaofeng Liao,et al.  Dynamics of Gut Microbiota in Autoimmune Lupus , 2014, Applied and Environmental Microbiology.

[36]  Qiang Feng,et al.  The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment , 2015, Nature Medicine.

[37]  E. Grice,et al.  Next-Generation Sequencing: A Review of Technologies and Tools for Wound Microbiome Research. , 2015, Advances in wound care.

[38]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[39]  Martin Hirst,et al.  High-resolution profiling and discovery of planarian small RNAs , 2009, Proceedings of the National Academy of Sciences.

[40]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[41]  Yong Dai,et al.  Analysis of microRNAs in patients with systemic lupus erythematosus, using Solexa deep sequencing , 2014, Connective tissue research.

[42]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[43]  C. Rivolta,et al.  Whole genome sequencing as a means to assess pathogenic mutations in medical genetics and cancer , 2014, Cellular and Molecular Life Sciences.

[44]  Yaran Yang,et al.  Application of Next-generation Sequencing Technology in Forensic Science , 2014, Genom. Proteom. Bioinform..

[45]  H. Buermans,et al.  Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions , 2012, Nucleic acids research.

[46]  Aaron Y. Lee,et al.  HLA-B27 and Human β2-Microglobulin Affect the Gut Microbiota of Transgenic Rats , 2014, PloS one.

[47]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[48]  G. Illei,et al.  Deep sequencing of short RNAs reveals novel microRNAs in minor salivary glands of patients with Sjögren's syndrome. , 2012, Oral diseases.

[49]  Catherine A. Osborne,et al.  Terminal restriction fragment length polymorphism (T-RFLP) profiling of bacterial 16S rRNA genes. , 2014, Methods in molecular biology.

[50]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[51]  Tony J. Kenna,et al.  Intestinal Dysbiosis in Ankylosing Spondylitis , 2016 .

[52]  Marta E Alarcón-Riquelme,et al.  A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus , 2006, Nature Genetics.

[53]  H. Young,et al.  Does the microbiota play a role in the pathogenesis of autoimmune diseases? , 2014, Gut.

[54]  D. Cooper,et al.  Exome sequencing: Dual role as a discovery and diagnostic tool , 2012, Annals of neurology.

[55]  Toshiro K. Ohsumi,et al.  A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency. , 2013, The Journal of allergy and clinical immunology.

[56]  Julie Hussin,et al.  Next-generation sequencing approaches for genetic mapping of complex diseases , 2012, Journal of Neuroimmunology.

[57]  Antonio J. Berlanga-Taylor,et al.  Rare variants in the CYP27B1 gene are associated with multiple sclerosis , 2011, Annals of neurology.

[58]  Om Prakash,et al.  Technicalities and Glitches of Terminal Restriction Fragment Length Polymorphism (T-RFLP) , 2014, Indian Journal of Microbiology.

[59]  K. Tokunaga,et al.  Association of Functional Polymorphisms in Interferon Regulatory Factor 2 (IRF2) with Susceptibility to Systemic Lupus Erythematosus: A Case-Control Association Study , 2014, PloS one.

[60]  D. Savage.  Microbial ecology of the gastrointestinal tract. , 1977, Annual review of microbiology.